Mutant p53-induced immortalization of primary human mammary epithelial cells

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3129-3133

  Gao, Qingshen ^a   Hauser, Stephen H ^a   Liu, Xiao Long ^a   Wazer, David E ^a   Madoc Jones, Hywell ^a   Band, Vimla ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; DELETION MUTANT; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MISSENSE MUTATION; NORTHERN BLOTTING; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; EPITHELIUM; FEMALE; G1 PHASE; GENE DELETION; GENE EXPRESSION; GENES, P53; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029940374     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Farber, E The multistep nature of cancer deveplopment. Cancer Res., 44: 4217-4223, 1984.
2. Barrett, J C Comparison of human versus rodent cell transformation: importance of cell aging In: J. S. Rhim and A. Dritschilo (eds), Neoplastic Transformation in Human Cell Culture. pp. 3-13. New York: Humana Press. 1991.
3. Hammond, S L., Ham, R. G , and Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract Proc. Natl. Acad. Sci USA, 81: 5435-5439, 1984.
4. Band, V., and Sager, R Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types Proc. Natl. Acad Sci. USA, 86 1249-1253, 1989.
5. Band, V., Zajchowski, D., Kulesa, V., and Sager, R Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements Proc. Natl Acad. Sci. USA, 87: 463-467, 1990
6. Band, V., DeCaprio, J A., Delmolino, L., Kulesa, V., and Sager, R. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J. Virol , 65; 6671-6676, 1991
7. Band, V , Dalal, S , Delmolino, L., and Androphy, E J. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J., 12: 1847-1852, 1993.
8. Scheffner, M., Werness, B. A., Huibregtse, J M., Levine, A. J , and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63 1129-1136, 1990
9. Dalal, S., Gao, Q , Androphy, E. J., and Band, V Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Virol , 70, 683-688, 1996.
10. Wazer, D E., Chu, Q , Liu, X-L., Gao, Q., Safaii, H , and Band, V Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol., 14, 2468-2478, 1994
11. Jego, N., Thomas, G., and Hamelin, R. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene, 8: 209-213, 1993
12. Runnebaum, I B., Nagarajan, M., Bowman, M , Soto, D., and Sukumar, S. Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. USA, 88: 10657-10661, 1991.
13. Malkin, D., Li, F. P., Strong, L C., Fraument, J. F. Jr., Nelson, C. E , Kim, D H., Kassel, J., Gryka, M A., Bischoff, F. Z., Tainsky, M A., and Friend, S. H. Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990
14. Srivastava, S., Zou, Z., Pirollo, K. Blattner, W , and Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome Nature (Lond), 348: 747-749, 1990.
15. Shay, J. W., Tomlinson, G., Piatyszek, M A , and Gollahon, L. S. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome Mol. Cell. Biol, 15: 425-432, 1995.
16. El-Deiry, W. S , Tokino, T , Velculescu, V. E., Levy, D. B , Parsons, R., Trent, J. M , Lin, D., Mercer, W. E , Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression Cell, 75: 817-825, 1993
17. Momand, J., Zambetti, G P , Olson, D. C., George, D , and Levine, A. J The mbm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245, 1992
18. Kastan, M B , Onyekwere, O , Sidransky, D , Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage Cancer Res., 51, 6304-6311, 1991.
19. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc Natl. Acad. Sci USA, 89, 7491-7495, 1992
20. Liu, X-L., Band, H., Gao, Q., Wazer, D E , Chu, Q., and Band, V. Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression. Carcinogenesis (Lond.), 15: 1969-1973, 1994.
21. Delmolino, L , Band, H., and Band, V. Expression and stability of p53 protein in normal human mammary epithelial cells. Carcinogenesis (Lond), 14: 827-832, 1993
22. Chirgwin, J. M., Przybyla, A E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 18, 5294-5299, 1979
23. Baker, S. J., Fearon, E. R. Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M , vanTuinen, P., Ledbetter, D H., Barker, D. F., Nakamura, Y , White, R , and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
24. Oliner, J D , Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. Oncoprotein mdm2 conceals the activation domains of tumour suppressor p53. Nature (Lond), 362: 857-860, 1993.
25. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249, 912-915, 1990.
26. Chen, J-Y., Funk, W. D., Wright, W. E., Shay, J. W., and Minna, J. D. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences Oncogene, 8: 2159-2166, 1993.
27. Prives, C. How loops, β sheets, and α helices help us to understand p53. Cell. 78: 543-546, 1994.
28. Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D., and Levine, A. J. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci USA, 90, 11623-11627, 1993.
29. 1 arrest and apoptosis. Cancer Res , 54: 1169-1174, 1994.
30. Milner, J , and Medcalf, E. A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell, 65: 765-774, 1991.
31. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
32. Takahashi, T., Nau, M M., Chiba, I , Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F , and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
33. Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., and Howley, P M. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins J. Virol., 66, 5100-5105, 1992.
34. Bond, J. A., Wyllie, F. S , and Wynford-Thomas, D Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene, 9: 1885-1889, 1994.
35. Forrester, K., Lupold, S E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., and Harris, C. C. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene, 10, 2103-2111, 1995.
36. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M , Finlay, C., and Levine, A J. Gain of function mutations in p53 Nat. Genet., 4: 42-46, 1993.
37. Levine, A. J , Chang, A , Dittmer, D., Notterman, D. A., Silver, A , Thorn, K., Welsh, D., and Wu, M. Seminars of the University of Minnesota The p53 tumor suppressor gene J Lab Clin Med , 123, 817-823, 1994.
38. Nigro, J. M., Baker, S J , Preisinger, A. C , Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S H , Davidson, N., Baylin, S., Devilee, P , Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C , and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 142: 705-708, 1989.